- Home
- INDO vs LTRN Comparison
INDO vs LTRN Comparison
Compare INDO & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDO
- LTRN
- Stock Information
- Founded
- INDO 2018
- LTRN 2013
- Country
- INDO Indonesia
- LTRN United States
- Employees
- INDO N/A
- LTRN N/A
- Industry
- INDO Oil & Gas Production
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- INDO Energy
- LTRN Health Care
- Exchange
- INDO Nasdaq
- LTRN Nasdaq
- Market Cap
- INDO 40.1M
- LTRN 46.7M
- IPO Year
- INDO 2019
- LTRN 2020
- Fundamental
- Price
- INDO $2.60
- LTRN $3.74
- Analyst Decision
- INDO
- LTRN Hold
- Analyst Count
- INDO 0
- LTRN 1
- Target Price
- INDO N/A
- LTRN N/A
- AVG Volume (30 Days)
- INDO 152.0K
- LTRN 47.1K
- Earning Date
- INDO 04-25-2025
- LTRN 05-08-2025
- Dividend Yield
- INDO N/A
- LTRN N/A
- EPS Growth
- INDO N/A
- LTRN N/A
- EPS
- INDO N/A
- LTRN N/A
- Revenue
- INDO $3,127,587.00
- LTRN N/A
- Revenue This Year
- INDO N/A
- LTRN N/A
- Revenue Next Year
- INDO N/A
- LTRN N/A
- P/E Ratio
- INDO N/A
- LTRN N/A
- Revenue Growth
- INDO N/A
- LTRN N/A
- 52 Week Low
- INDO $2.05
- LTRN $2.79
- 52 Week High
- INDO $6.65
- LTRN $11.99
- Technical
- Relative Strength Index (RSI)
- INDO 43.45
- LTRN 42.37
- Support Level
- INDO $2.50
- LTRN $3.40
- Resistance Level
- INDO $2.72
- LTRN $4.00
- Average True Range (ATR)
- INDO 0.14
- LTRN 0.33
- MACD
- INDO -0.01
- LTRN -0.04
- Stochastic Oscillator
- INDO 29.41
- LTRN 32.11
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.